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Introduction
Genomic instability is a hallmark of tumor progression, including in the breast cancers. Almost all solid tumors show genomic instability, which includes chromosome number abnormality (aneuploidy), chromosome structure abnormality (deletion, insertion, and translocation), as well as single nucleotide mutations on chromosome.
Many cellular mechanisms can induce genomic instability in cancer, such as mitotic apparatus defects, DNA damage, cell cycle check point defects, as well as cytokinesis failure or cell fusion. In mitosis, microtubule spindles play critical roles in condensed chromosome partition into daughter cells. It is conceivable that any defects in mitotic spindles will affect the chromosome segregation, which in turn leads to aneuploidy. This award focus on centrosome abnormality induced aneuploidy, one type of genomic instabilities in breast cancer cells, caused by a mitotic kinase: Aurora-A.
The eukaryotic centrosome is the microtubule organizing center and is composed of two perpendicularly positioned centrioles and surrounding amorphous pericentriolar materials (reviews , ), ) ) ) ). Four groups of protein kinases are found to associate with and regulate the centrosome replication cycle: cyclindependent kinases 
Body
In the effort to elucidate how Aurora-A overexpression inducing centrosome amplification, cellular transformation, and genomic instability, we performed a genetic screen to identify the interacting proteins of Aurora-A (Task 5-6). NM23-H1 was identified to interact with Aurora-A in a 2-hybrid screen. Association of the two proteins in human cells was confirmed by co-immunoprecipitation from cell lysates. Biochemical purification also indicates Aurora-A and NM23-H1 forms a stable, physical complex.
Both Aurora-A and NM23-H1 colocalize to centrosome throughout the cell cycle (see the reportable outcomes 1 and annual report 2003) In the effort to identify the Aurora-A substrate (Task 1-4), we purified the Aurora- In the two-hybrid screen, Astrin/DEEPEST, a microtubule-associated protein, was also identified as an Aurora-A interacting protein (Task 5,6).
Microtubules are composed of heterodimers of α and β-tubulins. The mitotic spindle, composed primarily of microtubules and associated proteins, is responsible for attaching to the condensed sister chromatids at the kinetochore and accurately segregating them to two daughter cells (Compton, 2000) . (Gruber et al., 2002) . In the absence of astrin, condensed chromosomes could not align to the spindle equator, ultimately leading to apoptosis (Gruber et al., 2002) .
Astrin was found to be phosphorylated by p34cdc2 kinase in vitro (Chang et al., 2001 ). (Chang et al., 2003) Astrin/DEEPEST was identified as an Aurora-A interacting protein by a two-hybrid screen ( Fig.1 ). Astrin and Aurora-A are co-expressed at mitosis and co-localize to mitotic spindles and to the outer kinetochore (Fig. 2) . RNAimediated depletion of astrin abolishes the localization of Aurora-A on mitotic spindles, however depletion of Aurora-A does not affect astrin localization (Fig.2, 3 ). Astrin silencing leads to a moderate mitotic cell cycle delay, that is correlated with de-localization of cyclin B1-CDK1 from the centrosomes and spindles and resembles the mitotic arrest phenotypes in siAurora-A treated cells (Fig.4) . Co-depletion of both astrin and Aurora-A causes a mitotic arrest phenotype similar to depletion of siAurora-A alone, suggesting that astrin acts upstream of Aurora-A (Fig.4) . Depletion of astrin, which interacts with α-tubulin, also induces Eg5 dependent multipolar spindles from de novo synthesized centrosomes without recruiting centrin 2 ( Although I worked on the screening using the hpRNA library and tested out the suppressor screen of siAurora-A in Hela cells to fulfill task 6 aiming at identifying the genetic suppressors for Aurora-A inactivation in mammalian system using the laboratory validated hpRNA library screening as proposed in the 2004 annual report, the results was not reportable due to the time incompatibility (see annual report 2004).
Research Accomplishment:
• In a two-hybrid screen looking for STK15 interacting proteins using full length STK15 as a bait, NM23-H1 was identified and characterized as an Aurora-A interacting partner associated in a protein complex at centrosome throughout the cell cycle (Task 
Conclusion:
We completed the proposal tasks 1 to 5 in the study. For task 6, Although I worked on the screening using the hpRNA library and tested out the suppressor screen of siAurora-A in Hela cells aiming at identifying the genetic suppressors for Aurora-A inactivation in mammalian system using the laboratory validated hpRNA library screening as proposed in the 2004 annual report, the results was not reportable.
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INTRODUCTION
Correct partitioning of the genome during mitosis depends upon the tightly regulated function of the mitotic spindle, which is composed of centrosomes, microtubules, molecular motors, chromosomes and kinetochores. The centrosome is the major microtubule-organizing center in mammalian cells and the counterpart to the spindle pole body of the yeast Saccharomyces cerevisiae. The centrosome in mammalian cells is composed of two perpendicularly positioned centrioles and the surrounding amorphous pericentriolar material. g-Tubulin and pericentrins are constitutive components of the centrosome, while other proteins, such as p53, pRB, BRCA1, BRCA2 and CDK2, accumulate at centrosomes in a cell cycle-dependent manner (1±4). The centrosome normally duplicates once per cell cycle. This process is initiated during G 1 after cells pass the restriction point and is completed during G 2 . Centrosomes separate at G 2 /M, migrating to opposite poles of the cell to establish the microtubule network that is required to separate condensed chromosomes during M phase. Centrosomes play a vital role in establishing spindle bipolarity, in assembling spindle microtubules and in determining the plane of cytokinesis (for reviews see 5±10). More recently, accumulating evidence suggests a more direct role than had previously been appreciated for the centrosome in cytokinesis and cell cycle progression during the following G 1 and S phases (11±13).
Centrosome abnormalities, including morphological alterations, supernumerary centrosomes and acentriolar centrosomes, have been demonstrated in most human cancer cells, including those derived from breast, prostate, lung, colon and brain (for reviews see 14,15; see also 2,16±18). Several oncogenes, tumor suppressor genes, cell division cycle and mitotic checkpoint genes are required for or involved in centrosome duplication, such as Ras, BRCA1 and BRCA2, CDK2, cyclin A and ATR (3,19±23) . Like other cellular processes, protein kinases play critical roles in the centrosome duplication process. Among the centrosomeassociated kinases, Aurora-A/AIK1/BTAK/STK15 kinase has been identi®ed as a candidate oncogene with connections to the centrosome cycle (24±27). Aurora-A/STK15 is overexpressed at both the mRNA and protein levels in a number of cancer cell lines, including breast, ovarian and prostate (25, 27) , and also in breast cancer tissues (28±30). Its kinase activity peaks at the G 2 /M phase of the cell cycle (25) . A mutant, kinase-inactive STK15 (Stk15 K162M) abolishes the oncogenic activity of STK15 in Rat1 ®broblasts, while a mutation conferring constitutive activation (Stk15 T288D) increases the kinase activity and enhances transforming potential (25) . These results strongly suggest that the kinase activity of STK15 is essential for STK15 function in vivo. STK15 is regulated by phosphorylation and ubiquitin-mediated degradation and interacts with CDC20 and protein phosphatase 1 (PP1) (31±35).
As a putative tumor suppressor, the nm23 gene was discovered on the basis of its reduced expression in highly metastatic cell lines (36) . Several studies have shown that NM23 overexpression can reduce the metastatic potential of melanoma and breast carcinoma cells in vivo (37±39). Furthermore, nm23 expression, at both the protein and mRNA levels, inversely correlates with high metastatic potential in numerous human cancers, including breast, gastric, cervical and ovarian carcinoma and melanoma (for a review see 40) . The nm23 genes encode a protein family with eight subfamilies in human (41) . The well characterized biochemical activities of these proteins include NDP kinase (42) , protein histidine kinase, histidine-dependent protein phosphotransferase (43±45) and serine autophosphorylation (46, 47) . Data suggest that it is the level of autophosphorylation that correlates with tumor suppression by NM23 in melanoma cells (46) . NM23 associates with the cytoskeleton through an interaction with b-tubulin (48). Awd, the¯y homolog of NM23, co-localizes with microtubules in Drosophila cells (49) and more recent data have indicated that NM23 may also be a component of the centrosome (50) .
Despite the strong evidence that STK15/Aurora-A/BTAK regulates centrosome duplication, cellular transformation and aneuploidy, little evidence directly connects this kinase with known oncogenes or tumor suppressors. Here we provide the data that STK15 interacts with the tumor suppressor NM23, both in yeast and in normal human ®broblasts. NM23 and STK15 co-fractionate in a high molecular weight complex and co-localize at centrosomes throughout the cell cycle.
MATERIALS AND METHODS

Plasmids and primers
Full-length STK15 was obtained by PCR from plasmid pcDNA3-STK15/BTAK (a kind gift from Dr S. Sen; 27) using the primers STK15-CHIS5 (CGGGATCCCGG-GGATGGACCGATCTAAAGAAACTGC) and STK15-3XhoI (CCGCTCGAGCTAAGACTGTTTGCTAGCTGA-TTC). STK15-GBT8 was constructed by cloning into the BamHI and XhoI sites of pGBT8. A HeLa cDNA two-hybrid library was used in the two-hybrid screen (51) . Full-length nm23-H1 cDNA was obtained by PCR of EST clones ordered from Genome Systems Inc. (EST clones 590228 and 3454119) using the primers NM23GAD-5EcoRI (CGGAATTCCA-TGGCCAACTGTGA-GCG) and NM23-3XhoI (CCGCTC-GAGTCATTCATAGATCCAG). pGADGH-NM23-H1 was constructed by cloning the the PCR product into the EcoRI and XhoI sites of pGADGH (51) .
Cell culture
Human IMR90 cells were purchased from ATCC (CCL-186). These were immortalized by infection with a hTERT retrovirus at passage 25 (52) . The cells were cultured at 37°C in a 5% CO 2 incubator in Dulbecco's modi®ed medium (DMEM) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS), 10% (v/v) non-essential amino acids (NEAA) and penicillin/streptomycin (100 IU/ml and 100 mg/ml, respectively). Nocodazole treatment was done by addition of 10 mg/ml nocodazole to the culture medium followed by incubation for 10 min at 37°C.
Two-hybrid screening
To identify proteins interacting with STK15, we screened a plasmid library of fusions between the GAL4 activation domain (GAD, residues 768±881) and HeLa cell cDNA fragments. The Gal4 DNA-binding domain (GBD) is fused with STK15 in the pSTK15-GBT8 construct. The screen was done in a S.cerevisiae reporter strain (pJ64-4a, W303MATa trp9-901, 112 ura3-52 his3-200 gal4 gal80 GAL2-ADE2 LYS2::GAL1-HIS3 met2::GAL7-LacZ, a kind gift from R. Rothstein). A total of 1.2 Q 10 6 transformants were assayed on synthetic drop-out medium (without leucine, histidine and tryptophan, SC ±HLW) plates. A total of 104 colonies turned blue on X-gal plates, and the plasmids were recovered from 54 colonies. Retransformation of the plasmids into the test strain con®rmed that 20 plasmids retained the ability to activate the b-galactosidase reporter. Sequencing analysis revealed four plasmids contained coding sequences from nm23-H1 genes. The four plasmids were derived from two independent cDNAs comprising nucleotides 25±330 and 4±159 of the nm23-H1 coding region.
Antibodies
A polyclonal antiserum against STK15 (anti-STK15) was raised in rabbits by presenting a KLH-conjugated nine amino acid peptide (synthesized by Research Genetics, Huntsville, AL) from the C-terminus of STK15 (NKESASKQS). The serum was af®nity puri®ed using a resin prepared from the synthesized peptide (53) . The antibody recognizes a 46 kDa band in whole cell lysates. For some studies, the af®nity-puri®ed antibody was labeled with Alexa Fluor 647 dye (Molecular Probes, Eugene, OR), for example for examination Immunoblotting, immunoprecipitation and¯uorescence microscopy IMR90 cells were lysed in IP buffer [125 mM NaCl, 1 mM Mg(OAc) 2 , 1 mM CaCl 2 , 5 mM EGTA, 20 mM HEPES (pH 7.6), 1% (v/v) NP-40, with freshly dissolved 2 mM DTT, 0.2 mM phenylmethylsulfonyl¯uoride and protease inhibitors (Roche, Mannheim, Germany)] on ice for 10±15 min. Protein concentrations were determined by Bradford assay (Bio-Rad). A total of 10±50 mg protein was analyzed by 10 or 12% (v/v) SDS±PAGE (54) .
Immunoprecipitation was performed as described (55) with the following modi®cations. IMR90 cells were lysed in IP buffer at 4°C for 10 min. The cell lysate was cleared by centrifugation at 10 000 g for 10 min at 4°C. The supernatant was pre-cleared by incubation for 30 min with agarose±protein A or agarose±protein G beads (Pierce). The supernatant was further incubated with 5 mg antibodies for 3±4 h at 4°C with agitation, after which agarose±protein A or A/G mixture (pre-blocked by incubation with 5% BSA) was added for 1 h at 4°C. The beads were then washed three times with IP buffer. For release of STK15 and associated proteins, beads were incubated with 1 mg/ml synthetic antigen in phosphate-buffered saline (PBS) for 1 h at 4°C with agitation. 
Biochemical fractionation of STK15 and NM23
For fractionation of STK15 and NM23, IMR90 cells were lysed as above and the lysates were cleared by centrifugation at 10 000 g for 10 min at 4°C. The supernatants were cleared by passage through a 0.2 mm ®lter and fractionated through three chromatographic steps, Mono S, Mono Q and Superose 6 HR10/30 (Amersham-Pharmacia Biotech, Piscataway, NJ), in an AKAT FPLC system. The cell lysates were loaded ®rst on Mono S and eluted with a linear gradient of from 100 to 1000 mM potassium chloride in MonoS buffer [20 mM HEPES (pH 7.6), 10% (v/v) glycerol, 1 mM DTT, 1 mM EDTA, 0.01% (v/v) NP40]. Fractions were collected (0.5 ml) and those containing the peak of STK15 1.5 ml (from 280 to 370 mM) were collected and dialyzed against MonoQ buffer [20 mM HEPES (pH 8.0), 10% (v/v) glycerol, 1 mM DTT, 1 mM EDTA, 0.01% (v/v) NP40, containing 100 mM NaCl]. The dialyzed eluate was then loaded onto Mono Q and was eluted with a linear gradient from 0 to 1000 mM potassium chloride in MonoQ buffer. The peak fractions for STK15 (from 350 to 450 mM) were collected and pooled before 0.5 ml was loaded onto Superose 6. The column was run at 0.4 ml/min with Super6 buffer [20 mM HEPES (pH 7.6), 10% (v/v) glycerol, 1 mM DTT, 1 mM EDTA, 0.01% NP40 and 300 mM NaCl]. Fractions of 1 ml were collected and proteins were precipitated with TCA. The pellets were then re-dissolved in 0.1 N NaOH and loaded onto SDS±PAGE gels for immunoblot analysis.
RESULTS AND DISCUSSION
NM23 and STK15 interact
To search for proteins that interact with STK15 we conducted a yeast two-hybrid screen using the full-length STK15 coding sequence as a bait (see Materials and Methods). Among the positives, we found four plasmids containing the human nm23-H1 coding sequence. Two different fusions were represented, which cover a common N-terminal region of NM23-H1 (three represented fusions of Gal4 to amino acids 9±110, and another represented amino acids 2±53). This suggests that the region of NM23-H1 between amino acids 2 and 53 binds directly to STK15. We inserted the full-length nm23-H1 coding sequence into pGADGH (pGADGH-NM23-H1) and con®rmed that this fusion protein also interacts speci®cally with STK15 (Fig. 1) . Only in combination with STK15 did colonies carrying NM23-H1 show signi®cant b-galactosidase expression. Neither NM23-H1 alone nor NM23 combined with other Gal4 fusion proteins (e.g. ras) induced b-galactosidase expression. However, at least in yeast, the degree of X-gal staining indicated that the interaction between STK15 and Nm-23H1 was relatively weak, as compared to the positive control (pGBT8-Ras and pGADGH-Raf in this case). It was therefore essential to investigate whether these proteins physically interacted in mammalian cells.
To test whether STK15 and NM23 also interact in vivo in human cells, proteins were immunoprecipitated from IMR90 cell lysates using anti-STK15 and anti-NM23 antibodies (see Materials and Methods). The presence of NM23 and STK15 in the precipitate was examined by western blotting (Fig. 2) . Anti-STK15 speci®cally co-immunoprecipitates STK15 and NM23. Pre-incubation of the STK15 antibody with its cognate synthetic antigen coordinately abolished immunoprecipitation of both STK15 and NM23 (Fig. 2, lanes 1 and 2) . The NM23 antiserum also immunoprecipitated NM23 and STK15, while normal mouse IgG did not bring down signi®cant amounts of either NM23 or STK15 (Fig. 2, lanes 3 and 4) . We did detect some non-speci®c binding of NM23 to protein A/G beads; however, this is not unexpected considering that NM23 is a relatively abundant protein (lane 3). The foregoing results indicate that STK15 and NM23 associate with each other in human cells. Comparing the total amount of NM23 present in the cell and the amount precipitated by anti-NM23-H1 antibody (Fig. 2, lane 4 , and western data not shown) to the amount of NM23 immunoprecipitated by the STK15 antibody (Fig. 2 , lane 2; both lanes 2 and 4 were from the same amount of cell lysate) suggests that a relatively small percentage of NM23-H1 exists in a stable, physical complex with STK15. In western blots of the anti-STK15 immunoprecipitations, we also detected another protein of~54 kDa, in addition to the 46 kDa protein that is predicted to be an STK15 protein derived from an alternatively spliced mRNA. We have not de®nitively determined the identity of the 54 kDa protein; however, the human genome sequencing project has predicted an alternatively spliced STK15 transcript that is predicted to generate a protein of this size (accession no. XP_009546). In contrast, we have con®rmed that the~46 kDa band is STK15 by MALDI-TOF mass spectrometry.
To verify the interaction between STK15 and NM23-H1, protein extracts from IMR90 cells were fractionated by FPLC. Throughout the puri®cation, we followed STK15 by western blotting. Western analysis of the puri®cation through Mono S, Mono Q and Superose 6 columns revealed that STK15 is present in two distinct forms, a high molecular weight protein complex (Fig. 3, fractions 10 and 11,~2 MDa) and a relatively low molecular weight complex (fractions 15±17,~350 KDa). NM23-H1 also shows a peak around fractions 15±17, which exactly co-migrates with STK15 in the~350 kDa complex (Fig. 3) . This result supports the notion that STK15 and NM23 coexist in a protein complex in vivo.
STK15 and NM23 co-localize at centrosomes
It has been shown that STK15 localizes to centrosomes in mitotic cells (25) (Fig. 4A) . By ®xing IMR90 cells in 0.5% (w/v) formaldehyde, we can also detect STK15 at centrosomes during interphase in immortalized human IMR90 cells. Centrosomes were visualized by simultaneous staining with an anti-centrin2 antiserum, which locates the two centrioles in the centrosome (Fig. 4) . The amount of STK15 at centrosomes increases as cells move from interphase to prophase, and SKT15 also becomes apparent on the mitotic spindle. These results suggest that STK15 is a centrosome component throughout the cell cycle (Fig. 4A ), but becomes enriched at centrosomes during mitosis. NM23-H1 also localizes to centrosomes in interphase cells (Fig. 4B) (50) . At the beginning of prophase NM23-H1 accumulates at the centrosome, as judged from the increased intensity of staining (Fig. 4B, prometaphase) (50) . The association of NM23 with centrosomes persists through the mitotic phase and NM23-H1 also distributes somewhat to the microtubule spindles adjacent to the centrosome from metaphase to telophase (Fig. 4B) (50) . From late telophase to cytokinesis, NM23-H1 also accumulates at the newly forming midbody microtubules (Figs 4C and 5C in late telophase and cytokinesis cells). Interestingly, an identical distribution pattern at the midbody microtubules is also observed for STK15 (Figs 4C and 5B in late telophase and cytokinesis cells). The accumulation of NM23-H1 on centrosomes coincides with the enrichment of STK15 at the centrosome and with increased STK15 kinase activity at the beginning of mitosis (25) .
In order to test whether STK15 and NM23 co-localize, we simultaneously labeled IMR90 cells with b-tubulin-FITC, NM23-TRITC and STK15-AF647 (Cy5) and visualized the localization of each protein (Fig. 4C) . b-Tubulin immunouorescence reveals interphase microtubule ®laments and centrosomes. In mitotic phase, b-tubulin localizes both to the mitotic spindles and to the centrosomes (Fig. 4C ). NM23 and STK15¯uorescence is present together at the centrosome at all cell cycle phases (Fig. 4C , the right side merged lane). These results con®rm that STK15 and at least some fraction of NM23 co-localize to centrosomes throughout the cell cycle.
STK15 and NM23 centrosomal localization is microtubule-independent
There is some evidence indicating that NM23-H1 is b-tubulin associated and localized through g-tubulin to centrosomes (48, 50) . In order to clarify that STK15 and NM23 do not associate indirectly at centrosomes through their separate interactions with microtubules, we treated IMR90 cells with nocodazole (see Materials and Methods), which rapidly dissipates the microtubule network in cells (Fig. 5B and C,  b-tubulin column) .
There are several centrosome-associated proteins that localize to this structure in a spindle-dependent fashion. Of these, perhaps the most well studied is g-tubulin (56). Upon nocodazole treatment of mammalian cells, centrosomal g-tubulin is reduced by~2-fold in interphase cells and by at least 4-fold in mitotic cells (56). Using b-and g-tubulin antisera, we con®rmed that our nocodazole treatment dissipates the microtubule network and dramatically reduces the amount of g-tubulin associated with the centrosome (Fig. 5A±C) . In such cells, STK15 and NM23-H1 still localize to the centrosome with the same pattern and intensity of staining seen in untreated cells (Fig. 5B and C) . The result suggests that the interaction between STK15 and NM23 and their centrosome localization are microtubule-independent.
A previous study (57) showed that the centrosomal localization of a Xenopus laevis homolog of STK15, Aurora-A, is microtubule-dependent. This result was obtained using a construct consisting of the only N-terminal domain of Aurora-A (57). However, microtubule-independent localization of Aurora-A to the centrosome was observed using a fulllength Aurora-A construct (57). Here, we also observed that the localization of full-length STK15 to the centrosome is not dependent on microtubules (Fig. 5B) .
A previous study showed that STK15 associates with centrosomes only at onset of mitosis (25) . However, our immuno¯uorescence studies indicate that STK15 associates with centrosomes throughout the cell cycle. This discrepancy could arise because of the different cell types used in these studies. Here we examined STK15 in normal or immortalized human ®broblasts cells while previous studies have used human cancer cells and rodent ®broblast cells. Furthermore, different antisera and ®xation conditions were used in this and in previous studies. We do, however, observe an increase in the abundance of STK15 at centrosomes in mitotic cells.
STK15 is a centrosome-associated kinase, overexpression of which in rodent or human cancer cells causes improper centrosome duplication, aneuploidy and cellular transformation (25, 27) . The abundance of STK15 is controlled by the ubiquitin pathway (32, 33) and has been linked to CDC20, an APC activator (31) . STK15 kinase activity is also controlled by PP1, a protein phosphatase (34) . Here we provide evidence that STK15 is associated with a putative tumor and metastasis suppressor protein, NM23-H1. These proteins physically interact and co-localize to centrosomes throughout the cell cycle in human IMR90 cells. NM23-H1 plays important roles in cell proliferation, differentiation, tumorigenesis and metastasis.
The interaction between NM23 and STK15 might potentially modulate either of their activities through a number of mechanisms, ranging from allosteric regulation to induced localization to enzymatic modi®cation. We tested the latter possibility using STK15 and NM23-H1, puri®ed from Escherichia coli. Puri®ed STK15 was enzymatically active, as judged by its ability to phosporylate a model substrate, MBP. NM23 also displayed activity as judged by autophosphorylation and NDP kinase activities (data not shown; 46,58). Neither of the puri®ed proteins was capable of chemically modifying the other nor did mixing these proteins affect their activities towards model substrates in vitro. Therefore, the exact nature of the functional relationship between NM23 and SKT15 remains unknown. T he eukaryotic centrosome is the microtubule-organizing center and is composed of two perpendicularly positioned centrioles and surrounding amorphous pericentriolar materials (for reviews, see refs. 1-6). Four groups of protein kinases are found to regulate the centrosome replication cycle: cyclindependent kinases (7-9), Polo-like kinases (10), NIMA kinases (11), and Aurora kinases. In mammalian cells, the Aurora kinase family has three members: Aurora-A, -B, and -C. Alterations in the expression and activity of Aurora-A͞serine͞threonine kinase 15 (STK15) affect genomic stability, disrupt the fidelity of centrosome duplication, and induce cellular transformation (12) (13) (14) (15) . Aurora-A is regulated by ubiquitin pathways and protein phosphorylation (16) (17) (18) (19) . A kinesin-related protein (Eg5), cytoplasmic polyadenylation element-binding protein (CPEB), and transforming acidic coiled-coil protein number 3 (TACC3) have been found to be substrates of Aurora-A (20) (21) (22) (23) .
Recently, p160ROCK has been identified as a centrosome component and functions in centrosome positioning and centrosome-dependent exit from mitosis (24) . p160ROCK is a member of Rho-associated serine-threonine protein kinases. p160ROCK͞Rho-kinase͞ROK kinases are involved in various cellular functions downstream of Rho, such as smooth muscle contraction, stress fiber formation, and cytokinesis (25) . p160ROCK phosphorylates LIM kinase and mDia, which then phosphorylates cofilin to regulate the Rho-induced reorganization of cytoskeleton (26) . p160ROCK has also been reported to interact with CDC25A in transforming growth factor ␤-induced cell cycle arrest (27) and to be involved in tumorigenesis (28, 29) , and apoptosis (30). Here we provide biochemical and genetic evidence that Aurora-A and p160ROCK associate physically and functionally in a protein complex. These proteins interact genetically, with suppression of p160ROCK alleviating the G 2 ͞M cell cycle arrest induced by inactivation of Aurora-A.
Materials and Methods
Cell Culture. Normal human foreskin fibroblast IMR90 cells were immortalized by hTERT expression, and early passage HeLa and LinXA (293Tt derivative as in ref. 31 ) were cultured as in ref. 32 . To assess mitotic spindle reassembly capacity in vivo, microtubules were disassembled with nocodazole and cold treatment (32) . The cells were incubated at 37°C for 10 min to promote spindle reassembly. This process was monitored by anti-␤-tubulin indirect immunofluorescence. p160ROCK specific inhibitor Y27632 (Calbiochem) was used at 100 M in Fig. 2b .
Antibodies. Affinity-purified anti-Aurora-A, anti-GST-Aurora-A sera (32), rabbit polyclonal anti-␥-tubulin, mouse monoclonal anti-␣-tubulin, anti-␤-tubulin (Sigma), rabbit anti-phospho-H3 (Ser-10, Upstate Biotechnology, Lake Placid, NY), mouse monoclonal anti-BrdUrd (Amersham Pharmacia), rabbit polyclonal anti-MAD2 (Covance, Berkeley, CA), anti-p160ROCK serum (a kind gift from Shuh Narumiya, Kyoto University, Kyoto), anti-BubR1 and anti-Bub1 (kind gifts from S. Taylor, Manchester, U.K.), anti-DDX3 and DDX6 (kind gifts from J. Sommerville, University of St. Andrews, St. Andrews, Scotland and A. H. Patel, Medical Research Council, Institute of Virology, Glasgow, U.K.) were used. Another rabbit polyclonal anti-p160ROCK antibody against the C-terminal 9 aa (VKNTS-GKTS) of p160ROCK was affinity-purified as in ref. 32 .
Immunoprecipitation, Immunofluorescence, Immunoblot, and Aurora-A Depletion Assay. Immunoprecipitation, immunofluorescence, and immunoblotting were as described in ref. 32 . Denaturing immunoprecipitation was done as in ref. 33 . To measure how much p160ROCK associates with Aurora-A in vivo, we used increasing amounts of anti-GST-Aurora-A serum, and found that Aurora-A in 1 ϫ 10 6 immortalized IMR90 cells can be 90% depleted by using 50 l of anti-GST-Aurora-A serum. In Fig. 1c , the same amount of anti-Aurora-A antibody was used and images on immunoblot were captured with Alphaimager 2200 and quantified by CHEMILMAGER V5.5 program (Alpha Innotech, San Leandro, CA). Peptide Sequencing, MS Analysis, and Sequence Identification. Preparative immunoprecipitates from 2.5 ϫ 10 8 IMR90 cells by using 1.5 mg of affinity-purified anti-Aurora-A antibody were resolved in 10% or 12% SDS-polyacrylamide gel and stained by Bio-Safe Coomassie G250 (Bio-Rad) or sequencing-grade Coomassie blue G250 (Sigma). Individual bands were excised and digested with trypsin, and peptides were fractionated by RP-HPLC. The MS sequencing was done in the Bio-medical Mass Spectrometry Facility at Washington University, St. Louis, as in ref. 34 .
RNA Interference (RNAi) in Transient Transfection. To design targetspecific small interfering RNA (siRNA) duplexes, AA(N19)dTdT type sequences were selected from the ORFs of the p160ROCK (AAGGTGATTGGTAGAGGTGCA), Aurora-A (AAGCA-CAAAAGCTTGTCTCCA), and GFP (TCAGCGTGTCCGGC-GAGGGCGA) (35) . The selected sequences were submitted to BLAST searches against the nonredundant protein database in National Center for Biotechnology Information to make sure that only the selected genes were targeted. The 21-nt RNAs purchased form Dharmacon (Lafayette, CO). In brief, 100 nM siRNA was used with transfection reagent Oligotransfectamine (Invitrogen) in HeLa cell transfections as in ref. 35 . The 24-, 48-, and 72-h time points had one, two, and three rounds of transfections, respectively. Cells were assayed 24 h after the last transfection. Apoptosis Assay. HeLa cells transfected in six-well cell-culture plates were trypsinized. The cells together with the culture media were spun down at 1,000 rpm in a tabletop centrifuge, and cells were stained with Hoechst 33342 to visualize the nuclei DNA morphology. Cells with intact uniform nuclei were counted as live cells and cells with fragmented nuclei, a signature of apoptosis cell, were counted as apoptotic cells (37) . Annexin V-FITC apoptosis detection kit II (BD Pharmingen) and terminal deoxynucleotidyltransferase-mediated dUTP nick endlabeling assay (In Situ cell death detection kit, Roche Applied Science) were used according to the manufacturers' instructions.
Results and Discussions
To identify regulators and substrates of Aurora-A kinase, immortalized human IMR90 fibroblast cells were labeled with 35 S and Aurora-A was immunoprecipitated from cell lysates with affinity purified polyclonal anti-Aurora-A antibodies. Nine protein bands associated specifically with the antibody (Fig. 1a) . We named the immunoprecipitated Aurora-A-bound protein STK15-associate factors (SAFs; see below).
The integrity of STK15 complexes is compromised in various breast and prostate cancer cell lines tested. However, SAF160 appears in every cell line examined, pointing to the potential importance of its association with Aurora-A (Fig. 1a) . To identify components of the Aurora-A complex, Aurora-Aassociated protein bands were excised and analyzed by matrixassisted laser desorption ionization-time-of-flight MS and electrospray ionization MS͞MS. Mass fingerprinting indicated that the 46-kDa protein was Aurora-A and that SAF160 was p160ROCK. Immunoblotting Aurora-A immunoprecipitates showed that anti-Aurora-A specifically immunoprecipitated Aurora-A, and p160ROCK, SAF68, and SAF55 (also identified as DDX3 and DDX6 by matrix-assisted laser desorption ionization-time-of-flight) (Fig. 1b) . Immunoblot analysis demonstrated that ␥-tubulin is not present at detectable levels in the SAF immunocomplex (data not shown). Therefore, it is unlikely that the purified SAF complex represents part of the centrosome that is indirectly associated with Aurora-A through ␥-tubulin. TPX2 has been found to interact with Aurora-A by immunoprecipitation (38) . However, we did not see a band of 100 kDa corresponding to TPX2 (Fig. 1a) . Use of different anti-Aurora-A antibodies, cell lines, and labeling methods may account for this discrepancy in the immunoprecipitation results.
To examine whether SAFs coexist with Aurora-A in a large multiprotein complex, IMR90 lysates were fractionated by FPLC. All the identified proteins cofractionated with Aurora-A on Mono S and Mono Q ion-exchange columns and on a third Superose 6 gel filtration column (Fig. 5a , which is supporting information on the PNAS web site). On Superose 6, Aurora-A split into two distinct peaks, indicating that Aurora-A exists in multiple protein complexes (Fig. 5b and ref. 32) . Immunodepletion with anti-GST-Aurora-A antibody in IMR90 cell lysates suggested that roughly half of endogenous p160ROCK associates with Aurora-A (Fig. 1c) , either at the centrosome or in the cytoplasm (24) .
We used RNAi to investigate consequences of suppressing Aurora-A or p160ROCK in HeLa cells. siRNAs dramatically reduced the expression of targeted proteins (Fig. 2a) . Immunofluorescence stains with anti-Aurora-A and -p160ROCK also confirmed the depletions. The depletion of Aurora-A also Cell lysates were immunoprecipitated with affinity-purified anti-Aurora-A antibody (␣Aurora-Aϩ lanes) or anti-Aurora-A plus cognate antigen polypeptide (␣Aurora-Aϩ͞cognate polypeptideϩ lanes) and were resolved on SDS-10% polyacrylamide gel and subjected to autoradiography. SAFs with numbers indicate the apparent molecular mass on the gel, starting from the largest component (160 kDa). Molecular mass markers are indicated on the left. (b) Anti-p160ROCK, -SAF68, -SAF55, and -Aurora-A immunoblotting on anti-Aurora-A immunoprecipitates from IMR90 cells. (c) IMR90 cell lysates that were either titrated with anti-GST-Aurora-A to remove Aurora-A protein, or with same amount of preimmune sera as a control were subjected to immunoblotting with anti-p160ROCK and Aurora-A. Tubulin was used as a loading control. significantly reduced the p160ROCK protein level (Fig. 2a) , consistent with the notion that two proteins interact in a complex in vivo (39) .
Twenty-four hours after transfection of siAurora-A, cells became rounder and grew more slowly than the control siGFPtransfected cells. Flow cytometry showed a significant increase in G 2 ͞M phase cells in comparison with that observed in the control siGFP-or siROCK-treated cells (Fig. 2b Right) . Notably, this cell cycle phenotype could be alleviated by simultaneous cotransfection of siRNAs directed against Aurora-A and p160ROCK (Fig. 2b Right, siAurora-AϩsiROCK). Correspondingly, a ROCK kinase specific inhibitor, Y27632, also showed a dosage-dependent suppression of the G 2 ͞M arrest phenotype in siAurora-A-transfected cells (Fig. 2b Right, siAurora-AϩY27632). These results demonstrate an epistatic relationship between Aurora-A and p160ROCK and indicate that they function in the same genetic pathway.
The observed phenotypes were also confirmed by immunofluorescence staining of cells with anti-phospho-H3 antibody, a mitotic marker that specifically labels cells from the beginning of prophase to the end of anaphase (Fig. 2c) . Quantitation of anti-phospho-H3 staining by flow cytometry supported interpretations from the immunofluorescence studies (data not shown). BrdUrd incorporation to assess the S-phase population did not show a noticeable difference in the transfected cells at any time point (data not shown). The significantly prolonged mitotic phase correlated with an increased frequency of apoptosis (Fig. 2d) , which was also confirmed by annexin V staining and terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling assays (data not shown) and a decrease in surviving cell numbers as measured by plotting growth curves (Fig. 2e) . Again, cotransfection of siROCK together with siAurora-A partially rescued the apoptotic phenotype ( Fig. 2 d and e) .
Because Aurora-A is a centrosomal kinase, we next assessed the integrity of mitotic spindles and examined centrosome and nuclear morphologies in siAurora-A-transfected cells (Fig. 3) . Most mitotic cells contained abnormal spindles with disorganized arrays of microtubules and fewer and shorter spindles than in normal control cells (Fig. 3b , anti-␣-tubulin columns in siAurora-A images). In addition, comparison of the spindle lengths, intensities, and levels of the anti-␣-tubulin stains in siAurora-A-treated cells with those of siGFP control cells showed that the spindle microtubule networks in Aurora-Adepleted cells did not extend to the condensed prometaphase chromosomes (Fig. 3 a and b, anti-␣-tubulin columns) . Some of the abnormal spindles still apparently radiated from centrosomes (Fig. 3b) . Others had multiple origins that did not always colocalize with centrosomes or concentrations of ␥-tubulin (Fig.  3b , anti-␣-tubulin stains indicated by triangles). The portion of cells with abnormal spindles increased dramatically over the time course of the experiment (Fig. 4a) . This outcome is the most prominent defect in the siAurora-A-transfected cells. Anti-␥-tubulin staining showed that with abnormal mitotic spindles, multiple concentrated spots of ␥-tubulin occurred in the cytoplasm (Fig. 3b , anti-␥-tubulin spots indicated with arrows). Suppression of Aurora-A also induced centrosome amplification in interphase cells (Fig. 4b) . Although chromosomes condensed at prometaphase in arrested mitotic cells, virtually no normal metaphase and anaphase mitotic figures were found in these transfected cells, suggesting cells arrested at prometaphase (Fig.  3b) . Live cell imaging over a 4-h time course showed no progression of the arrested cells to metaphase, whereas control cells progressed from prometaphase through anaphase in Ϸ50 min (data not shown). siRNAs to Aurora-A also resulted in a significant accumulation of binucleated cells (Fig. 4c) . Many nuclei had satellite micronuclei around the major interphase nucleus. In addition, many nuclei showed irregular undefined edges and shapes, a phenotype that often accompanies genomic instability and aneuploidy. The cell population with these unusual nuclear morphologies increased dramatically over the time course of the experiment (Figs. siAurora-A, 4C portion 2b Left, and 4c), indicating an increase in genomic instability of the cells. The mitotic spindle defects we observed here are closely resemble to those recently observed in Aurora-A-depleted HeLa cells (38, 40) .
In siROCK-transfected cells, the number of cells with multiple mitotic spindles and the number of cells with apparent centrosome amplification in interphase cells increased significantly in comparison with siGFP control cells (Fig. 4 a and b) . A dramatic increase in mitotic spindle reassembly capacity was also observed in siROCK-transfected cells (see Materials and Methods). Eighty percent of mitotic cells showed multiple, reassembled mitotic spindle networks after transient treatment with nocodazole (Fig.  3c , anti-␣-tubulin columns in siROCK images), in comparison with 20% of control cells. The result showed the siROCKtransfected cells are highly prone to reassembling inappropriate mitotic spindles using nascent ␥-tubulin spots. In accordance with this result, we observed an increase in aneuploid cells (Figs.  siROCK, 4C portion 2b Left, and 4c) . Also, siROCK transfection caused nuclear fragmentation (Fig. 4c) . However, a dramatic increase did not occur in multinucleated cell populations (Fig.  4c) . This result suggests that depletion of p160ROCK alone can give rise to aneuploid cells, although to a lesser degree than does loss of Aurora-A.
Again, we found the mitotic arrest caused by suppression of Aurora-A was alleviated by coincident depletion of p160ROCK (Fig. 2 b Right, siAurora-AϩsiROCK, and c). Cotransfection of both siAurora-A and siROCK led to assemble of functional mitotic spindles (Fig. 3d , anti-␣-tubulin columns in siAuroraAϩsiROCK images), completion of mitosis, regrouping of split centrosomes into two functional groups for organizing bipolar spindles (Fig. 3d , anti-␥-tubulin columns in siAuroraAϩsiROCK images), and greater accumulation of aneuploid cells (Figs. siAurora-AϩsiROCK, 4C portion 2b Left, and 4c).
The immunoprecipitated Aurora-A not only phosphorylated an artificial substrate, myelin basic protein, but also phosphorylated a p160 in the SAF complex ( Fig. 6 a and b , which is published as supporting information on the PNAS web site). This finding was confirmed by denaturing IP to be p160ROCK (Fig.  6c) . Aurora-A also phosphorylated another protein, p82, in purified centrosomes (Fig. 6 a and b) . Phosphorylation of p160ROCK in the immunoprecipitated Aurora-A complex can be specifically increased in cells transfected with constructs encoding Aurora-A, but not a mutant Aurora-A K162M, which lacks kinase activity (41) (Fig. 6d) . In fact, [ 32 P]orthophosphate labeling indicated that phosphorylation of p160ROCK in the cells expressing a kinase dead Aurora-A K162M mutant appreciably decreased, suggesting that Aurora-A is responsible, at least in part, for p160ROCK phosphorylation in vivo (Fig. 6e , comparing P-p160ROCK band intensity in K162M lane with those in other control lanes). Phosphoamino acid analysis of excised 32 P-labeled p160ROCK band showed that only serine residue(s) are phosphorylated (Fig. 7a , which is published as supporting information on the PNAS web site). In vitro kinase assays with various GST-p160ROCK fusion proteins as substrates for Aurora-A (Fig. 7b , all fusion proteins started from N terminus of p160ROCK and ended at the indicated amino acids) showed GST-p160ROCK1034 was significantly labeled, but not GST-p160ROCK726 or other fusion proteins (Fig. 7c) , suggesting the phosphorylated serine residues are located between 726 and 1,034 aa of p160ROCK.
A G 2 ͞M delay phenotype had been reported after overexpression of Aurora-A in HeLa cells (42) . A similar mitotic defect is also observed on Aurora-A loss-of-function in Drosophila melanogaster and in S 2 cells (ref. 43 and data not shown) and most recently in HeLa cells (40, 44) . These results together with our observation indicate that balance of Aurora-A protein in the cell is critical and that either down-or up-regulation of its protein level will compromise its function and lead to mitotic defects. Suppression of aurora-A (aurora-1) in Caenorhabditis elegans by RNAi does not affect centrosome separation, but mitotic spindle formation (45) , similar to what we observed here in HeLa cells. However, in D. melanogaster syncytial embryos, aurora mutations cause centrosome separation defects, which result in monopolar spindles and abnormal mitoses. The differences between these observed phenotypes could be due to cell type-specific functions of Aurora kinases. However, we favor the notion that different genetic lesions (e.g., point mutation versus nearly, but not complete suppression by RNAi versus null mutations) leads to different phenotypic outcomes. Although a causal relationship between phosphorylation of p160ROCK by Aurora-A and suppression of mitotic arrest has not been firmly established here, our results indicate that p160ROCK acts downstream of Aurora-A in a common genetic pathway and phosphorylation of p160ROCK by Aurora-A may mimic the depletion of p160ROCK to bypass the mitosis arrest caused by Aurora-A inactivation.
